| Hans-Günter Meyer-Thompson | Gabapentinoide
Increasing Worldwide Evidence of Harms Associated With Gabapentinoids, Particularly Pregabalin
Increasing Worldwide Evidence of Harms Associated With Gabapentinoids, Particularly Pregabalin
With increased use of gabapentinoids (gabapentin and pregabalin) for a wide a variety of indications, there has been growing evidence of harms. Two recent studies—one in Sweden and the other in Australia—looked at national data to investigate harms associated with gabapentinoid use. (Alcohol, Other Drugs, and Health: Current Evidence, Boston University, USA, 29.10.2019)